BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38079329)

  • 1. Design, synthesis, biological evaluations and in silico studies of N-substituted 2,4-thiazolidinedione derivatives as potential a-glucosidase inhibitors.
    Dahiya L; Kumar R; Baidya ATK; Kumar S; Kumar R; Pawar SV; Yadav AK
    J Biomol Struct Dyn; 2023 Dec; ():1-18. PubMed ID: 38079329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, α-glucosidase and α-amylase inhibitory activities, acute toxicity and molecular docking studies of thiazolidine-2,4-diones derivatives.
    Fettach S; Thari FZ; Hafidi Z; Tachallait H; Karrouchi K; El Achouri M; Cherrah Y; Sefrioui H; Bougrin K; Faouzi MEA
    J Biomol Struct Dyn; 2022 Nov; 40(18):8340-8351. PubMed ID: 33847536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diphenyl-substituted triazine derivatives: synthesis, α-glucosidase inhibitory activity, kinetics and
    Shamim S; Khan KM; Ali M; Mahdavi M; Salar U; Mohammadi-Khanaposhtani M; Faramarzi MA; Ullah N; Taha M
    Future Med Chem; 2023 Sep; 15(18):1651-1668. PubMed ID: 37727987
    [No Abstract]   [Full Text] [Related]  

  • 4. Imidazo[1,2-c]quinazolines as a novel and potent scaffold of α-glucosidase inhibitors: design, synthesis, biological evaluations, and in silico studies.
    Peytam F; Hosseini FS; Hekmati M; Bayati B; Moghadam MS; Emamgholipour Z; Firoozpour L; Mojtabavi S; Faramarzi MA; Sadat-Ebrahimi SE; Tehrani MB; Foroumadi A
    Sci Rep; 2023 Sep; 13(1):15672. PubMed ID: 37735489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Molecular Docking Studies and ADME Prediction of Some New Albendazole Derivatives as α-Glucosidase Inhibitors.
    Senkardes S; Kulabas N; Kucukguzel SG
    Acta Chim Slov; 2022 Sep; 69(3):526-535. PubMed ID: 36196815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xanthones as potential α-glucosidase non-competition inhibitors: Synthesis, inhibitory activities, and in silico studies.
    Wang L; Ai C; Jin C; Mou J; Deng Y
    Chem Biol Drug Des; 2023 Sep; 102(3):547-556. PubMed ID: 37249098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological evaluation and molecular docking studies of novel benzimidazole derivatives.
    Singh G; Singh A; Verma RK; Mall R; Azeem U
    Comput Biol Chem; 2018 Feb; 72():45-52. PubMed ID: 29346072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico evaluation of phenolic compounds as inhibitors of Α-amylase and Α-glucosidase.
    Abdelli I; Benariba N; Adjdir S; Fekhikher Z; Daoud I; Terki M; Benramdane H; Ghalem S
    J Biomol Struct Dyn; 2021 Feb; 39(3):816-822. PubMed ID: 31955660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis, In Silico Testing, and In Vitro Evaluation of Thiazolidinone-Based Benzothiazole Derivatives as Inhibitors of α-Amylase and α-Glucosidase.
    Khan S; Iqbal S; Khan M; Rehman W; Shah M; Hussain R; Rasheed L; Khan Y; Dera AA; Pashameah RA; Alzahrani E; Farouk AE
    Pharmaceuticals (Basel); 2022 Sep; 15(10):. PubMed ID: 36297276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as α-Glucosidase Inhibitors.
    Gong Z; Xie Z; Qiu J; Wang G
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29084182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New 4-phenylpiperazine-carbodithioate-N-phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α-glucosidase enzymes.
    Mohammadi-Khanaposhtani M; Nori M; Valizadeh Y; Javanshir S; Dastyafteh N; Moaazam A; Hosseini S; Larijani B; Adibi H; Biglar M; Hamedifar H; Mahdavi M; Kamci H; Karakus A; Taslimi P
    Arch Pharm (Weinheim); 2022 May; 355(5):e2100313. PubMed ID: 35132681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2,4-Dichloro-5-[(N-aryl/alkyl)sulfamoyl]benzoic Acid Derivatives: In Vitro Antidiabetic Activity, Molecular Modeling and In silico ADMET Screening.
    Thakral S; Singh V
    Med Chem; 2019; 15(2):186-195. PubMed ID: 30251608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of flavonoids from banana pseudostem and flower (quercetin and catechin) as potent inhibitors of α-glucosidase: An in silico perspective.
    Patil SM; Martiz RM; Ramu R; Shirahatti PS; Prakash A; Kumar BRP; Kumar N
    J Biomol Struct Dyn; 2022; 40(23):12491-12505. PubMed ID: 34488558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationship studies of benzimidazole-thioquinoline derivatives as α-glucosidase inhibitors.
    Moghadam Farid S; Noori M; Nazari Montazer M; Khalili Ghomi M; Mollazadeh M; Dastyafteh N; Irajie C; Zomorodian K; Mirfazli SS; Mojtabavi S; Faramarzi MA; Larijani B; Iraji A; Mahdavi M
    Sci Rep; 2023 Mar; 13(1):4392. PubMed ID: 36928433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Evaluation of 1,3,5-Triaryl-2-Pyrazoline Derivatives as Potent Dual Inhibitors of Urease and α-Glucosidase Together with Their Cytotoxic, Molecular Modeling and Drug-Likeness Studies.
    Mehmood R; Sadiq A; Alsantali RI; Mughal EU; Alsharif MA; Naeem N; Javid A; Al-Rooqi MM; Chaudhry GE; Ahmed SA
    ACS Omega; 2022 Feb; 7(4):3775-3795. PubMed ID: 35128286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors.
    Pogaku V; Gangarapu K; Basavoju S; Tatapudi KK; Katragadda SB
    Bioorg Chem; 2019 Dec; 93():103307. PubMed ID: 31585262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological, toxicological and molecular docking evaluations of isoxazoline-thiazolidine-2,4-dione analogues as new class of anti-hyperglycemic agents.
    Fettach S; Thari FZ; Hafidi Z; Karrouchi K; Bouathmany K; Cherrah Y; El Achouri M; Benbacer L; El Mzibri M; Sefrioui H; Bougrin K; Faouzi MEA
    J Biomol Struct Dyn; 2023 Feb; 41(3):1072-1084. PubMed ID: 34957934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, in vitro, and in silico biological evaluations of coumarin-indole hybrids as new anti-α-glucosidase agents.
    Niri DR; Sayahi MH; Behrouz S; Moazzam A; Mojtabavi S; Faramarzi MA; Larijani B; Rastegar H; Mohammadi-Khanaposhtani M; Mahdavi M
    BMC Chem; 2022 Nov; 16(1):84. PubMed ID: 36329490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Biologically Hybrid Pharmacophore Thiazolidinone-Based Indole Derivatives: Synthesis, In Vitro Αlpha-Amylase and Αlpha-Glucosidase Along with Molecular Docking Investigations.
    Khan S; Iqbal S; Rahim F; Shah M; Hussain R; Alrbyawi H; Rehman W; Dera AA; Rasheed L; Somaily HH; Pashameah RA; Alzahrani E; Farouk AE
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular dynamics simulations reveal the inhibitory mechanism of Withanolide A against α-glucosidase and α-amylase.
    Oyewusi HA; Wu YS; Safi SZ; Wahab RA; Hatta MHM; Batumalaie K
    J Biomol Struct Dyn; 2023; 41(13):6203-6218. PubMed ID: 35904027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.